This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

CCS Medical Announces Agreement With LifeScan

FARMERS BRANCH, Texas, March 6, 2013 /PRNewswire/ -- CCS Medical announced today that is has entered into an agreement with LifeScan, Inc., to provide diabetes testing supplies to patients across the country. 

(Logo: http://photos.prnewswire.com/prnh/20130306/FL72774LOGO )

"This agreement means that CCS Medical is a LifeScan Direct Mail Order Supplier with the ability to serve all Medicare beneficiaries and many commercial plan members who use LifeScan products, such as LifeScan's OneTouch® Ultra® meter and test strips," said Dirk Allison, CCS Medical President and Chief Executive Officer. 

"This is a tremendous development for CCS Medical that will enhance our leadership role within the industry," said Allison.  "We are excited about our renewed partnership with an industry leader such as LifeScan, which serves to further validate our mission of providing high-quality products to our patients at a low price."  

About CCS Medical  Established in 1994, CCS Medical is a rapidly growing provider of low-cost, high-quality products and services delivered directly to homes of patients with chronic conditions.  The company offers a single source solution for diabetes testing supplies, insulin pumps, catheters, ostomy supplies, advanced wound care dressings, incontinence supplies, and prescription medications.  CCS Medical's patient-centered model specializes in convenient home delivery, product education, and insurance processing.  CCS Medical is a privately held company and its largest shareholders are funds managed by Highland Capital Management, L.P.  More information is available at www.ccsmed.com.

 

SOURCE CCS Medical

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,096.90 -106.47 -0.58%
S&P 500 2,098.53 -9.25 -0.44%
NASDAQ 4,967.1410 -12.76 -0.26%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs